Finance
Biopharmaceutical company reports second quarter financial results
Published in Obesity and Diabetes Week, March 15th, 2004
Palatin reported total revenues for the second quarter of fiscal year ending June 30, 2004, of $291,354 and a net loss of $4.6 million or $0.10 per share. In the second quarter of fiscal year ended June 30, 2003, total revenues were $233,505 and net loss was $4.5 million, or $0.18 per share.
The slight increase in net loss for the quarter ended December 31, 2003, compared to December 31, 2002, was mainly attributable to increases in operating expenses related to ongoing clinical trials and advancement of PT-141, the company's product under investigation for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetic Retinopathy
Angiotensin types 1 and 2 receptors mediate retinal VEGF expression - Insulin Resistance
Role of insulin resistance in polycystic ovary syndrome reviewed - Childhood Obesity
Changing socio-cultural paradigms linked to obesity risk in refugee children - Diabetes Complications
Perinephric abscess can result from insulin syringe reuse - Type 2 Diabetes Therapy
Exercise must be tailored to optimize glycemic control in diabetes - Blood Glucose
Glucose biosensor based on microcantilever developed - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
